FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149258443> ?p ?o ?g. }

• W2149258443 endingPage "2319" @default.
• W2149258443 startingPage "2310" @default.
• W2149258443 abstract "Recent data have suggested that patients with coronary disease in large arteries are at increased risk for late cardiac events after percutaneous intervention with first-generation drug-eluting stents, as compared with bare-metal stents. We sought to confirm this observation and to assess whether this increase in risk was also seen with second-generation drug-eluting stents.We randomly assigned 2314 patients needing stents that were 3.0 mm or more in diameter to receive sirolimus-eluting, everolimus-eluting, or bare-metal stents. The primary end point was the composite of death from cardiac causes or nonfatal myocardial infarction at 2 years. Late events (occurring during months 7 to 24) and target-vessel revascularization were the main secondary end points.The rates of the primary end point were 2.6% among patients receiving sirolimus-eluting stents, 3.2% among those receiving everolimus-eluting stents, and 4.8% among those receiving bare-metal stents, with no significant differences between patients receiving either drug-eluting stent and those receiving bare-metal stents. There were also no significant between-group differences in the rate of late events or in the rate of death, myocardial infarction, or stent thrombosis. Rates of target-vessel revascularization for reasons unrelated to myocardial infarction were 3.7% among patients receiving sirolimus-eluting stents, 3.1% among those receiving everolimus-eluting stents, and 8.9% among those receiving bare-metal stents. The rate of target-vessel revascularization was significantly reduced among patients receiving either drug-eluting stent, as compared with a bare-metal stent, with no significant difference between the two types of drug-eluting stents.In patients requiring stenting of large coronary arteries, no significant differences were found among sirolimus-eluting, everolimus-eluting, and bare-metal stents with respect to the rate of death or myocardial infarction. With the two drug-eluting stents, similar reductions in rates of target-vessel revascularization were seen. (Funded by the Basel Cardiovascular Research Foundation and the Swiss National Foundation for Research; Current Controlled Trials number, ISRCTN72444640.)." @default.
• W2149258443 created "2016-06-24" @default.
• W2149258443 creator A5002050515 @default.
• W2149258443 creator A5010017598 @default.
• W2149258443 creator A5011647440 @default.
• W2149258443 creator A5017583358 @default.
• W2149258443 creator A5035818862 @default.
• W2149258443 creator A5042435666 @default.
• W2149258443 creator A5053779611 @default.
• W2149258443 creator A5055700473 @default.
• W2149258443 creator A5057864298 @default.
• W2149258443 creator A5058074808 @default.
• W2149258443 creator A5063387567 @default.
• W2149258443 creator A5078302229 @default.
• W2149258443 creator A5087879929 @default.
• W2149258443 creator A5090925294 @default.
• W2149258443 date "2010-12-09" @default.
• W2149258443 modified "2023-09-29" @default.
• W2149258443 title "Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries" @default.
• W2149258443 cites W111155722 @default.
• W2149258443 cites W1433020779 @default.
• W2149258443 cites W1692359805 @default.
• W2149258443 cites W1739627328 @default.
• W2149258443 cites W1795635013 @default.
• W2149258443 cites W1980710226 @default.
• W2149258443 cites W1994506260 @default.
• W2149258443 cites W1997207240 @default.
• W2149258443 cites W2009589924 @default.
• W2149258443 cites W2028592017 @default.
• W2149258443 cites W2047021474 @default.
• W2149258443 cites W2049107440 @default.
• W2149258443 cites W2049992346 @default.
• W2149258443 cites W2073122940 @default.
• W2149258443 cites W2076983043 @default.
• W2149258443 cites W207753036 @default.
• W2149258443 cites W2082511254 @default.
• W2149258443 cites W2087150869 @default.
• W2149258443 cites W2098225657 @default.
• W2149258443 cites W2112708809 @default.
• W2149258443 cites W2120754408 @default.
• W2149258443 cites W2125716797 @default.
• W2149258443 cites W2139998313 @default.
• W2149258443 cites W2142075142 @default.
• W2149258443 cites W2149520588 @default.
• W2149258443 cites W2151225187 @default.
• W2149258443 cites W2165457109 @default.
• W2149258443 cites W2165993944 @default.
• W2149258443 cites W2210189158 @default.
• W2149258443 cites W4210546750 @default.
• W2149258443 doi "https://doi.org/10.1056/nejmoa1009406" @default.
• W2149258443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21080780" @default.
• W2149258443 hasPublicationYear "2010" @default.
• W2149258443 type Work @default.
• W2149258443 sameAs 2149258443 @default.
• W2149258443 citedByCount "234" @default.
• W2149258443 countsByYear W21492584432012 @default.
• W2149258443 countsByYear W21492584432013 @default.
• W2149258443 countsByYear W21492584432014 @default.
• W2149258443 countsByYear W21492584432015 @default.
• W2149258443 countsByYear W21492584432016 @default.
• W2149258443 countsByYear W21492584432017 @default.
• W2149258443 countsByYear W21492584432018 @default.
• W2149258443 countsByYear W21492584432019 @default.
• W2149258443 countsByYear W21492584432020 @default.
• W2149258443 countsByYear W21492584432021 @default.
• W2149258443 countsByYear W21492584432022 @default.
• W2149258443 countsByYear W21492584432023 @default.
• W2149258443 crossrefType "journal-article" @default.
• W2149258443 hasAuthorship W2149258443A5002050515 @default.
• W2149258443 hasAuthorship W2149258443A5010017598 @default.
• W2149258443 hasAuthorship W2149258443A5011647440 @default.
• W2149258443 hasAuthorship W2149258443A5017583358 @default.
• W2149258443 hasAuthorship W2149258443A5035818862 @default.
• W2149258443 hasAuthorship W2149258443A5042435666 @default.
• W2149258443 hasAuthorship W2149258443A5053779611 @default.
• W2149258443 hasAuthorship W2149258443A5055700473 @default.
• W2149258443 hasAuthorship W2149258443A5057864298 @default.
• W2149258443 hasAuthorship W2149258443A5058074808 @default.
• W2149258443 hasAuthorship W2149258443A5063387567 @default.
• W2149258443 hasAuthorship W2149258443A5078302229 @default.
• W2149258443 hasAuthorship W2149258443A5087879929 @default.
• W2149258443 hasAuthorship W2149258443A5090925294 @default.
• W2149258443 hasBestOaLocation W21492584431 @default.
• W2149258443 hasConcept C126322002 @default.
• W2149258443 hasConcept C141071460 @default.
• W2149258443 hasConcept C164705383 @default.
• W2149258443 hasConcept C2776820930 @default.
• W2149258443 hasConcept C2777546689 @default.
• W2149258443 hasConcept C2777921159 @default.
• W2149258443 hasConcept C2778213512 @default.
• W2149258443 hasConcept C2778283817 @default.
• W2149258443 hasConcept C2778583881 @default.
• W2149258443 hasConcept C2778742706 @default.
• W2149258443 hasConcept C2779464278 @default.
• W2149258443 hasConcept C2779699572 @default.
• W2149258443 hasConcept C2779983491 @default.
• W2149258443 hasConcept C2780400711 @default.
• W2149258443 hasConcept C3019562390 @default.

• next